Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial

Abstract Background Traumatic brain injury (TBI) is a major cause of death and disability across all ages. After the primary impact, the pathophysiologic process of secondary brain injury consists of a neuroinflammation response that critically leads to irreversible brain damage in the first days af...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Inge A. M. van Erp, Thomas A. van Essen, Kees Fluiter, Erik van Zwet, Peter van Vliet, Frank Baas, Iain Haitsma, Dagmar Verbaan, Bert Coert, Godard C. W. de Ruiter, Wouter A. Moojen, Mathieu van der Jagt, Wilco C. Peul
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	Traumatic brain injury C1-inhibitor Neuroinflammation Randomized controlled trials Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/b89b282f61b84e6a94a926ddd61fe737
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial

Ejemplares similares